Recurrent hepatitis C virus (HCV), fibrosis progression following liver transplantation: Impact of donor steatosis

被引：0
|
作者：
Botha, JF [1 ]
Thompson, E [1 ]
Gilroy, R [1 ]
Grant, W [1 ]
Sudan, D [1 ]
Shaw, B [1 ]
Langnas, A [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE 68198 USA
来源：
LIVER TRANSPLANTATION | 2006年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：C114 / C114
页数：1
相关论文
共 50 条
  • [1] Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation
    Botha, Jean F.
    Thompson, Eric
    Gilroy, Richard
    Grant, Wendy J.
    Mukherjee, Sandeep
    Lyden, Elizabeth R.
    Fox, Ira J.
    Sudan, Debra L.
    Shaw, Byers W., Jr.
    Langnas, Alan N.
    [J]. LIVER INTERNATIONAL, 2007, 27 (06) : 758 - 763
  • [2] A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation
    Yilmaz, Nevin
    Shiffman, Mitchell L.
    Stravitz, R. Todd
    Sterling, Richard K.
    Luketic, Velimir A.
    Sanyal, Arun J.
    Mills, A. Scott
    Contos, Melissa J.
    Coterell, Adrian
    Maluf, Daniel
    Posner, Marc P.
    Fisher, Robert A.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (07) : 975 - 983
  • [3] HCV RNA expression is associated with steatosis in recurrent hepatitis C virus infection following orthotopic liver transplantation
    Petrovic, LM
    Lloyd, RV
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 292A - 292A
  • [4] HCV RNA expression is associated with steatosis in recurrent hepatitis C virus infection following orthotopic liver transplantation
    Petrovic, LM
    Lloyd, RV
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 292A - 292A
  • [5] Fibrosis progression in patients with recurrent hepatitis C following living donor and cadaveric liver transplantation.
    Shiffman, ML
    Stravitz, RT
    Sterling, RK
    Luketic, VA
    Sanyal, AJ
    Contos, MJ
    Mills, AS
    Cotterell, A
    Maluf, D
    Posner, MP
    Fisher, RA
    [J]. LIVER TRANSPLANTATION, 2004, 10 (06) : C1 - C1
  • [6] DONOR LIVER STEATOSIS OF >30% HAS NO IMPACT ON HEPATITIS C VIRUS RECURRENCE FOLLOWING LIVER TRANSPLANTATION
    Gopasetty, Mahesh S.
    Taber, David
    Hughes, Michel
    Lin, Angello
    McGillicuddy, John
    Bratton, Charles
    Baliga, Prabhakar
    Chavin, Kenneth
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S130 - S130
  • [7] Donor Liver Steatosis of >30% Has No Impact on Hepatitis C Virus Recurrence Following Liver Transplantation.
    Gopasetty, Mahesh
    Taber, David
    Hughes, Michel
    Lin, Angello
    Mcgillicuddy, John
    Bratton, Charles
    Baliga, Prabhakar
    Chavin, Kenneth
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 610 - 610
  • [8] Occult hepatitis B virus infection in liver transplantation recipients with recurrent hepatitis C: Relationship with donor age and fibrosis progression
    Toniutto, P
    Minisini, R
    Burlone, M
    Biletta, E
    Fabris, C
    De Feo, TM
    Avellini, C
    Marangoni, F
    Fumo, E
    Giordano, F
    Pirisi, M
    [J]. HEPATOLOGY, 2005, 42 (04) : 318A - 318A
  • [9] Impact of Donor Liver Steatosis/Fibrosis Progression on Allograft Outcome in a Cohort of 203 Post Transplant Recurrent Hepatitis C Patients
    Ramineni, M.
    Moeller, M.
    Brown, K.
    Shah, V.
    [J]. MODERN PATHOLOGY, 2010, 23 : 370A - 370A
  • [10] Impact of Donor Liver Steatosis/Fibrosis Progression on Allograft Outcome in a Cohort of 203 Post Transplant Recurrent Hepatitis C Patients
    Ramineni, M.
    Moeller, M.
    Brown, K.
    Shah, V.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 370A - 370A
12345